NDC directory

Dexmethylphenidate Hydrochloride Extended-Release

dexmethylphenidate hydrochloride · Sandoz Inc · CAPSULE, EXTENDED RELEASE

0781-2734NDA AUTHORIZED GENERICCentral Nervous System Stimulant [EPC]
Product NDC
0781-2734
Generic name
dexmethylphenidate hydrochloride
Labeler name
Sandoz Inc
Dea schedule
CII
Brand name
Dexmethylphenidate Hydrochloride Extended-Release
Brand name suffix
Extended-Release
Finished
true
Listing expiration date
20271231
Marketing category
NDA AUTHORIZED GENERIC
Dosage form
CAPSULE, EXTENDED RELEASE
SPL ID
71f56227-d87a-4bc0-a879-c1993c6ccba6
Product type
HUMAN PRESCRIPTION DRUG
Marketing start date
20261001
Product ID
0781-2734_71f56227-d87a-4bc0-a879-c1993c6ccba6
Application number
NDA021802
Brand name base
Dexmethylphenidate Hydrochloride
Active ingredients
  1. Name
    DEXMETHYLPHENIDATE HYDROCHLORIDE
    Strength
    40 mg/1
Packaging
  1. Package NDC
    0781-2734-31
    Description
    30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0781-2734-31)
    Marketing start date
    20261001
    Sample
    false
Route
ORAL
Pharm class
Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.